#United States #New York #Levi & Korsinsky #Lawsuit #Hims & Hers

Important Notice for Hims & Hers Health, Inc. Investors

Hims & Hers Health, Inc. (NYSE: HIMS) is currently facing a class action securities lawsuit, and investors are urged to be aware of the critical deadlines approaching. The legal representation, Levi & Korsinsky, LLP, has notified shareholders that they can pursue recovery for losses incurred due to alleged securities fraud.

Overview of the Class Action Lawsuit

The lawsuit concerns claims that occurred between April 29, 2025, and June 23, 2025. During this period, severe allegations surfaced against Hims & Hers Health, Inc., asserting that the company was involved in deceptive practices related to the promotion and sale of illegitimate products. Specifically, it was alleged that Hims & Hers marketed unauthorized versions of the weight-loss drug Wegovy®, jeopardizing patient safety. As a result of these actions, there were heightened risks that the partnership with the pharmaceutical giant Novo Nordisk could be at risk, which further compromised investor confidence.

Investor Rights and Important Dates

Shareholders who experienced financial losses during the aforementioned timeframe need to act quickly. The deadline to nominate a lead plaintiff for the class action is August 25, 2025. Interested parties can secure their positions by contacting Levi & Korsinsky directly or via their online submissions.

Investors are reminded that participating in this class action incurs no out-of-pocket fees or obligations. Compensation may be awarded to those classified as class members without any initial financial outlay.

Contact Information

If you believe you have a claim regarding your investment in Hims & Hers Health, Inc., you can reach out to Joseph E. Levi at Levi & Korsinsky, LLP. Communication can be made through email at [email protected] or through telephone at (212) 363-7500. Levi & Korsinsky practices primarily in collective class action litigation, and they have a successful history of representing aggrieved shareholders.

Why Choose Levi & Korsinsky

With over two decades of experience in the legal field, Levi & Korsinsky has a proven track record of successfully retrieving hundreds of millions of dollars for shareholders. Their dedicated team specializes in complex securities litigation and consistently ranks among the top firms across the United States in this area. Their commitment to serving investor rights is evident through their extensive resources and successful legal strategies.

Conclusion

If you are an investor in Hims & Hers Health, Inc. and have concerns regarding your investment due to the allegations outlined, it is essential to take timely action before the deadline on August 25, 2025. With potential for recovery existent, it is vital to understand your rights and pursue necessary legal remedies to safeguard your interests.

For further information regarding the lawsuit and to determine your eligibility for the class action status, visit the official Levi & Korsinsky website or contact a representative today. Ensure that your rights as an investor are upheld and take proactive measures in the face of these legal challenges.